References

The genetics of kidney stone disease and nephrocalcinosis

10.1038/s41581-021-00513-4 · 2022 · External reference

Management of kidney stones in 2020

10.1001/jama.2020.0662 · 2020 · External reference

Kidney stone pathophysiology, evaluation and management: core curriculum 2023

10.1053/j.ajkd.2023.03.017 · 2023 · External reference

Kidney stones

10.1038/nrdp.2016.8 · 2016 · External reference

Determining the true burden of kidney stone disease

10.1038/s41581-020-0320-7 · 2020 · External reference

Dyslipidemia is associated with an increased risk of nephrolithiasis

10.1007/s00240-014-0719-3 · 2015 · External reference

Association between dyslipidemia and nephrolithiasis risk in a Chinese population

10.1159/000496208 · 2019 · External reference

The impacts of metabolic syndrome on the risk of severe urolithiasis

10.1007/s00240-022-01328-z · 2022 · External reference

Dysregulated palmitic acid metabolism promotes the formation of renal calcium-oxalate stones through ferroptosis induced by polyunsaturated fatty acids/phosphatidic acid

10.1007/s00018-024-05145-y · 2024 · External reference

Krϋppel-like factors (KLFs) in renal physiology and disease

10.1016/j.ebiom.2019.01.021 · 2019 · External reference

Matrix-stiffness–regulated inverse expression of Krüppel-like factor 5 and Krüppel-like factor 4 in the pathogenesis of renal fibrosis

10.1016/j.ajpath.2015.05.019 · 2015 · External reference

Prevention of LPS-induced acute kidney injury in mice by bavachin and its potential mechanisms

10.3390/antiox11112096 · 2022 · External reference

Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la/KLF5 pathway

10.1016/j.redox.2024.103246 · 2024 · External reference

Transcriptional regulation of adipogenesis, Compr

2017 · External reference

Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy

10.1093/eurheartj/ehy903 · 2019 · External reference

Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: involvement of reduced PPARγ expression

10.1016/j.redox.2019.101412 · 2020 · External reference

Epigenetic histone modulations of PPARγ and related pathways contribute to olanzapine-induced metabolic disorders

10.1016/j.phrs.2020.104703 · 2020 · External reference

The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases

10.1186/s40035-024-00398-w · 2024 · External reference

Probucol ameliorates renal injury in diabetic nephropathy by inhibiting the expression of the redox enzyme p66Shc

10.1016/j.redox.2017.07.002 · 2017 · External reference

Effect of probucol in a murine model of slowly progressive polycystic kidney disease

10.1016/s0272-6386(00)70330-1 · 2000 · External reference

Probucol protects against contrast-induced acute kidney injury via the extracellular signal-regulated kinases 1 and 2 (ERK1/2)/JNK-caspase 3 pathway in diabetic rats

10.12659/msm.913106 · 2019 · External reference

Antioxidants, statins, and atherosclerosis

10.1016/s0735-1097(03)00082-2 · 2003 · External reference

Probucol alleviates atherosclerosis and improves high density lipoprotein function

10.1186/1476-511x-10-210 · 2011 · External reference

Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases

10.1042/cs20171574 · 2018 · External reference

Sirtuin1 suppresses calcium oxalate nephropathy via inhibition of renal proximal tubular cell ferroptosis through PGC-1α-mediated transcriptional coactivation

2024 · External reference

Mechanism of calcium oxalate renal stone formation and renal tubular cell injury

10.1111/j.1442-2042.2007.01953.x · 2008 · External reference

Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation

10.1038/s41581-020-00392-1 · 2021 · External reference

Identification of biomarkers and potential therapeutic targets of kidney stone disease using bioinformatics

10.1007/s00345-023-04704-5 · 2024 · External reference

Mycobacterium tuberculosis 19-kDa lipoprotein induces toll-like receptor 2-dependent peroxisome proliferator-activated receptor γ expression and promotes inflammatory responses in human macrophages

10.3892/mmr.2014.3070 · 2015 · External reference

Transcriptome analysis after PPARγ activation in human meibomian gland epithelial cells (hMGEC)

10.1016/j.jtos.2019.02.003 · 2019 · External reference

Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease

10.1016/j.kint.2021.10.039 · 2022 · External reference

Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism

10.1016/j.cmet.2020.10.019 · 2020 · External reference

Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity

10.1016/j.molcel.2021.08.027 · 2021 · External reference

Melatonin alleviates palmitic acid-induced mitochondrial dysfunction by reducing oxidative stress and enhancing autophagy in bovine endometrial epithelial cells

10.1186/s40104-024-01064-x · 2024 · External reference

Perilipin 2 and age-related metabolic diseases: a new perspective, trends endocrin

2016 · External reference

A transcriptional regulatory loop of master regulator transcription factors, PPARG, and fatty acid synthesis promotes esophageal adenocarcinoma

10.1158/0008-5472.can-20-0652 · 2021 · External reference

Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation

10.1016/j.cmet.2004.11.005 · 2005 · External reference

Keep your fingers off my DNA: protein–protein interactions mediated by C2H2 zinc finger domains

10.1007/s12013-008-9008-5 · 2008 · External reference

Hepatic peroxisome proliferator-activated receptor-γ–fat-specific protein 27 pathway contributes to obesity-related hypertension via afferent vagal signals

10.1093/eurheartj/ehr265 · 2012 · External reference

Effects of fatty acids on inducing endoplasmic reticulum stress in bovine mammary epithelial cells

10.3168/jds.2019-18080 · 2020 · External reference

Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways

10.1016/j.atherosclerosis.2009.10.032 · 2010 · External reference

Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity

10.1152/ajpendo.00076.2013 · 2013 · External reference

SRSF1 promotes vascular smooth muscle cell proliferation through a Δ133p53/EGR1/KLF5 pathway

10.1038/ncomms16016 · 2017 · External reference

Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway

10.1186/s12935-019-0787-0 · 2019 · External reference

Probucol therapy improves long-term (>10-year) survival after complete revascularization: a propensity analysis

10.1016/j.atherosclerosis.2011.09.051 · 2012 · External reference

Did we abandon probucol too soon?

10.1097/mol.0000000000000199 · 2015 · External reference

New horizons for probucol, an old, mysterious drug

10.5551/jat.ed132 · 2021 · External reference

Probucol inhibits ABCA1-mediated cellular lipid efflux

10.1161/01.atv.0000148706.15947.8a · 2004 · External reference

An in vivo pharmacological study: variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques

10.1371/journal.pone.0214984 · 2019 · External reference

Pharmacokinetics and tolerability of probucol after multiple oral administrations in healthy volunteers

10.5414/cp201525 · 2011 · External reference